Simplify trial participation with direct-to-patient supplies powered by Signant SmartSignals RTSM, which enables at-home delivery with the flexibility to change or override study configuration options, as well as shipment tracking visibility and full oversight/traceability for the sponsor and sites. 

PROOF AT THE SPEED OF LIFE

Signant SmartSignals    RTSM

Direct-to-Patient 
Clinical Supply Management

ADDRESS COMMON 
DIRECT-TO-PATIENT 
DELIVERY CHALLENGES

Our direct-to-patent capabilities overcome challenges such as secure patient address management, integration with leading clinical trial distribution partners, and flexibility to accommodate country regulations and site/patient preferences, to provide supply chain visibility to both patients and sites.

Our Solutions are Better Together

SUPPLY ACCOUNTABILITY

CLINICAL SUPPLY CHAIN

FORECASTING & PLANNING

Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at  www.signanthealth.com.  

Resources

AVOID THESE PITFALLS

Direct-to-patient models that do not properly manage
final delivery can lead to a lack of full chain of custody,
resulting in:

• Audit findings 
• A negative trial experience for the patient and site 
• An increased workload for the site 
  

KEY FEATURES

1.  Address Management
Patient addresses are securely stored and encrypted for distribution partners only.

2.  Integration with Couriers
Sites gain full visibility to shipments in transit via leading couriers. Patients may also receive delivery updates through an optional app.

3.  Investigator Oversight
Ensure proper drug release and dosing control.

4.  Full Traceability
Online reports provide full tracking, oversight and traceability to the investigator and sponsor.

5.  Flexibility
Allow sites and patients to choose whether to receive medication at site or at home on a per-visit basis, as needed.

PUT PATIENTS FIRST

Signant's direct-to-patient capabilities provide last mile delivery of clinical supplies directly to the patient's home as well as shipment tracking from the distribution vendor, similar to modern consumer apps.

• Sites have visibility of shipments in transit to patients as well as received deliveries
  
• Shipments are sent directly to the patient, eliminating the need for site pickup                                                      
• Flexibility to accommodate patient address changes